506
史堡』L型盘查!Q!!生!旦笠i!鲞蔓!塑£!i!』墼尘坐:』!!Y!!!!:!!!:!L盥!:1
282.
[6]LauKK,Suzuki
H,Novak
J,eta1.Pathogenesisof
Henoch.
SchSnleinpurpuranephritis.PediatrNephrol,2010,25:19-26.7
al—SheyyabM,BatiehaA,e1.ShantiH,eta1.Henoeh—Schonleinpurpuraand
streptococcal
infection:a
prospectivecase—control
study.AnnTropPaediatr,1999,19:253-255.
[8]王秉慧,周丽群,左亚华.儿童腹型过敏性紫癜与幽门螺杆菌
感染的关系探讨.中国当代儿科杂志,2007,9:367-369.[9]Weiss
PF,Klink
AJ,LuanX,eta1.Temporalassociation
of
Streptococcus,Staphylococcus,and
parainfluenzapediatric
hospitalizations
and
hospitalized
cases
of
Henoch—Schonlein
purpura.JRheumatol,2010.37:2587-2594.[10]Cioc
AM,Sedmak
DD,NuovoGJ,et
a1.Parvovirus
B19
associatedadult
HenochSchonlein
purpura.J
Cutan
Path01.
2002,29:602-607.11
LimCS,Lim
SL.Henoch.Schonlein
purpura
associated
with
Mycoplasmapneumoniaeinfection.Cuffs,2011.87:273-276.
[12]Watanabe
T.Henoch-Schonlein
purpurafollowing
influenza
vaccinationsduringthepandemicofinfluenzaA(H1N1).PediatrNephrol,201l,26:795-798.
[13]Shu
M,Liu
Q,Wang
J,eta1.Measlesvaccineadverseevents
repofledinthemassvaccinationcampaignof
Sichuanprovince,
Chinafrom2007
to
2008.Vaccine,2011,29:3507-3510.
[14]张碧丽,王文红,范树颖.儿童过敏性紫575例分析.中华儿科
杂志,2001,39:646-649.[15]Aktas
B,TopcuogluP,KurtOK,eta1.SevereHenoch—Sehfinlein
purpurainducedby
cytarabine.AnnPharmacother,2009,43:
792-793.
[16]ZinkA,EruiS,FliegnerM.Antibiotics,purpuraandulcers:a
leukocytoclasticvaseulitis
after
clarithromycin.Dtsch
Med
Wochenschr,2006,13l:2217-2220.[17]HenggeUR,JochumC,TschakaJjan
E,eta1.Purpurafulminans.
A
fatat
consequenceof
a
widelyused
medication7.Hautarzt.
2002,53:483-487.
[18]ten
Holder
SM,Joy
MS,Falk
RJ.Cutaneous
and
systemic
manifestations
of
drug—induced
vasculitis.Ann
Pharmacother.
2002,36:130 147.
[19]Pons
R,Escutia
B.
Ciprofloxacin—induced
vasculitis
with
cutaneous
andrenalinvolvement.Nefrologia,2001,21:209-212.
[20]Derungs
A,EberhardtK,HeinigerU,eta1.Possibleaggravation
of
a
Henoch
Sehoenlein
purpura
by
isotretinoin.Praxis(Bern
1994),2012,101:827-837.
[21]Escudero
A,LucasE,VidalJB,et
a1.Drug.relatedHenoch—
SehijnleinPurpura.AllergolImmunopathol(Madr),1996,24:22—24.
[22]Kaneko
K,lgarashiJ,SuzukiY,eta1.Carbamazepine.induced
thrnmbocytopeniaandleucopeniacomplicatedbyHenoch—Sehtinleinpurpurasymptoms.Eur
JPediatr,1993,152:769-770.
[23]Rolle
AS,ZimmermannB,PoonSH.Etanercept—induced
Henoch—
Schd,nleinpurpuraina
patientwithankylosingspondylitis.JClin
Rheumatol,2013,19:90-93.
[24]SaulsburyF.Henoch—Schfnleinpurpura.Curt
OpinRheumat01.
2010,22:598-602.
[25]任少敏,杨光路,仝林虎,等.蒙汉族儿童过敏性紫癜I临床特
点与HLA—DRBI基因关联性对比分析.中华风湿病学杂志,
2003.7:469-473.
[26]吴春蕾,樊忠民,夏正坤,等.血管紧张素原基因多态性与儿
童过敏性紫癜及紫癜性肾炎的关系.1临床儿科杂志,2009,27:
314_316.
[27]杨军,李成荣,李永柏,等.甘露糖结合凝集素基因多态性与中
国汉族儿童过敏性紫癜的相关性研究.中国当代儿科杂志,
2003.5:523-526.
[28]李晶,王一冰,刘华林,等.过敏性紫癜P.选择素基因-2123位
点多态性检测与临床分析.中国当代儿科杂志,2011,13:278.
281
万方数据
[29]Saulsbury
FT.Henoch.Schsnleinpurpurainchildren.Report
of
100patientsandreviewoftheliterature.Medicine(Baltimore),
1999.78:395_409.
『30]OzenS.Thespectrumofvaseulitisinchildren.BestPracResClin
Rheumatol,2002,16:411.425.
[31]Trapani
S,MicheliA,GrisoliaF,et
a1.Henoeh-Seh6nlein
Purpurainchildhood:epidemiologicalandclinicalanalysisof150
casesover
a
5
year
periodandreviewofliterature.SeminArthritis
Rheum.2005,35:143.153.32
SanoH。IzumidaM.ShimizuH,eta1.Riskfactorsof
renal
involvementand
significant
proteinuria
in
Henoch—Sch6nlein
purpura.Eur
JPediatr,2002,161:196-2叭.
[33]ChangWL,Yang
YH,LinYT,eta1.Renalmanifestationsin
Henoch—Seh6nlein
purpura:a
10
year
elinical
study.Pediatr
Nephrol,2005.20:1269—1272.34
Ha"IS,Lee
JS.Scrotal
involvementinchildhood
Henoch—
Seh6nleinpurpura.ActaPaediatr,2007,96:552-555.
[35]Wen
YK,YangY,Chang
CC.Cerebralvasculitisand
intracerebralhemorrhageinHenoch—SchSnlein
purpura
treatedwith
plasmapheresis.PediatrNephrol,2005,20:223-225.
[36]Nadrous
HF,YuAC,SpecksU,eta1.Pulmonaryinvolvementin
Henoch-Sehfinleinpurpura.Mayo
Clin
Proc,2004,79:1151—
1157.
[37]Fretzayas
A,SiontiI,MoustakiM,et
a1.Henoch—Seh6nlein
purpura:along—term
prospectivestudyinGreekchildren.JClin
Rheumatol,2008,14:324.331.
[38]Weiss
PF,KlinkAJ,HexemK,eta1.Variationin
inpatient
therapyand
diagnostic
evaluationof
children
with
Henoch
Sch6nlein
purpura.JPediatr.2009,155:812-818.
[39]TizardEJ.Henoch-Sch6nleinpurpura.ArchDisChild,1999。80:
380-383.
[40]Ozen
S,RupeaoN,DillonMJ,et
a1.EULAR/PReSendorsed
consensus
criteriafortheclassificationof
childhoodvasculitides.
AnnRheumDis,2()06.65:936-941.
[41]SunderkfitterC,BonsmannG,SindrilaruA,eta1.Managementof
leukocytoclastic
vaseulitis.JDermatolTreat,2005,16:193-206.
[42]RonkainenJ,Koskimies
O,Ala—Houhala
M,et
a1.Earlyprednisonetherapyin
Henoeh-Sehtinleinpurpura:a
randomized,
double—blind,placebo—controlledtrial.JPediatr,2006,149:241—247.
【43JReinehrT,BtirkG,AndlerW.Does
steroidtreatmentof
abdominalpain
preventrenal
involvement
in
Henoch.Seh6nlein
purpura7.JPediatrGastroenterolNutr.2000.31:323-324.
[44]Wortmann
SB,Fiselier
TJ,VanDeKarNC,eta1.Refractory
severe
intestinalvaseulitis
due
to
Henoch—Sehfnlein
puroura.
successfultreatment
withplasmapheresis.ActaPaediatr,2006,95:
622-623.
[45]Lamireau
T,
RebouissouxL,Hehunstre
JP.Intravenous
immunoglobulintherapy
for
severe
digestive
manifestations
of
Henoch—SehOnleinpurpura.AetaPaediatr,2001,90:1081—1082.
[46]Wang
L,Huang
FC,Ko
SF,eta1.Successfultreatment
of
mesentericvasculitis
caused
by
Henoeh—SchSnleinpurpura
with
methylprednisolonepulsetherapy.ClinRheumatol,2003,22:140.142.
[47]Martin
S,CramerCH,HeikenenJ,eta1.Gastrointestinal
symptomsofHenoch—Sehsnleinpurpuratreatedwithmycophenolate
mofetil.JPediatrGastroenterolNutr,2006,43:245-247.
[48]Rettig
P,Cron
RQ.Methotrexate
usedas
a
steroid—sparingagentin
non—renalchronic
Henoch—Seh6nlein
purpura.
Clin
Exp
Rheumatol,2003,21:767-769.
诊治循证指南(试行)解读(二).中华儿科杂志,2009,47:
914-916.
PF,KlinkAJ,Localio
R,eta1.Cortieosteroids
may
improveclinical
outcomes
duringhospitalization
for
Henoch—
[49]黄松明,李秋,郭艳芳.紫癜性。肾炎的诊治:儿童常见肾脏疾病
[50]Weiss